ai in drug approval, biocon, biotech, biotech public markets, biotechnology startups in india, boston, business, business leaders, celebrities, china biotech ecosystem, china's pharmaceutical regulations, drug discovery investment, entrepreneurs, healthcare investment in india, high-risk biotech innovation, india, india bioeconomy growth, india's pharmaceutical innovation, influencers, investing in r&d, karnataka more than 50k, new drug therapies, nse, people, pharmacy of the world, politics, public market access for biotech, regulatory reform in india, sebi research-stage listing, venture capital in biotech